{"id":177069,"date":"2014-02-13T00:00:00","date_gmt":"2014-02-12T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/informations-recentes-fevrier-2014-co-dergocrine\/"},"modified":"2026-04-02T19:11:27","modified_gmt":"2026-04-02T17:11:27","slug":"informations-recentes-fevrier-2014-co-dergocrine","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/fr\/informations-recentes-fevrier-2014-co-dergocrine\/","title":{"rendered":"INFORMATIONS RECENTES FEVRIER 2014\u00a0: co-dergocrine"},"content":{"rendered":"<div class='tekst'>\n<p>\u00a0<\/p>\n<ul>\n<li>Il n\u00a0\u2018y a pas de nouveaut\u00e9 \u00e0 base de nouveau principe actif.<\/li>\n<li>Les sp\u00e9cialit\u00e9s <strong>Hydergine<\/strong>\u00ae et <strong>Ibexone<\/strong>\u00ae\u00a0\u00e0 base de <strong>co-dergocrine<\/strong>\u00a0 (syn. dihydroergotoxine) qui \u00e9taient propos\u00e9es dans le traitement des troubles vasculaires centraux sont retir\u00e9es du march\u00e9. Cela fait suite \u00e0 la d\u00e9cision de l\u2019Agence europ\u00e9enne des m\u00e9dicaments de limiter l\u2019usage des m\u00e9dicaments contenant des d\u00e9riv\u00e9s de l\u2019ergot de seigle dans les troubles circulatoires&#x002C; cognitifs et neuro-sensoriels ainsi que dans la pr\u00e9vention de la migraine&#x002C; et ce en raison de leur rapport b\u00e9n\u00e9fice-risque jug\u00e9 n\u00e9gatif.\u00a0 Cette recommandation est bas\u00e9e sur une r\u00e9\u00e9valuation des donn\u00e9es montrant un risque accru de fibrose et d\u2019ergotisme avec ces m\u00e9dicaments pour un b\u00e9n\u00e9fice mal d\u00e9fini dans ces indications. [voir aussi <a href='https:\/\/www.fagg-afmps.be\/fr\/news'>https:\/\/www.fagg-afmps.be\/fr\/news<\/a>; communiqu\u00e9 du 10\/07\/13]<\/li>\n<\/ul><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 Il n\u00a0\u2018y a pas de nouveaut\u00e9 \u00e0 base de  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,179],"tags":[20213,20224],"class_list":["post-177069","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2014-fr","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=177069"}],"version-history":[{"count":1,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177069\/revisions"}],"predecessor-version":[{"id":179643,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177069\/revisions\/179643"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=177069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=177069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=177069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}